ARTICLE | Company News
Pfizer withdraws EU application for Macugen label extension
July 20, 2011 12:21 AM UTC
Pfizer Inc. (NYSE:PFE) withdrew an application to extend the label for Macugen pegaptanib in Europe to include visual impairment due to diabetic macular edema. According to EMA, Pfizer made the decisi...